Clinical Trial Update: A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.

View source ↗

Summary

An observational trial update shows Pacitol Inj. (NCT06126016), sponsored by Boryung Pharmaceutical Co., Ltd, is being studied for efficacy and safety in patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hyperparathyroidism

Drugs mentioned

• Pacitol Inj.

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Chronic Kidney Disease 5D, Secondary Hyperparathyroidism | Status: RECRUITING